SentiAR Overview
- Founded
- 2017
- Status
- Private
- Employees
- 17
- Latest Deal Type
- Series A
- Latest Deal Amount
- $2M
- Investors
- 14
SentiAR General Information
Description
Developer of a 3D augmented reality platform designed to transform the experience for both patients and clinicians in interventional procedures. The company's platform features real-time holographic visualization of the patient's actual anatomy and utilizes a hands-free, head-up display to change the way data and imaging results are displayed in the operating room, enabling clinicians to treat and analyze cardiac arrhythmias within an interventional catheter lab environment.
Contact Information
Website
www.sentiar.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Healthcare Technology Systems
Primary Office
- 212 Kingshighway Boulevard
- Suite 115
- Saint Louis, MO 63108
- United States
+1 (314) 000-0000
SentiAR Timeline
SentiAR Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Early Stage VC (Series A) | 01-Dec-2021 | $2M | 00.00 | 000.00 | Completed | Generating Revenue |
| 6. Later Stage VC (Series A) | 01-Jan-2021 | 00.00 | 00.00 | 000.00 | Completed | Generating Revenue |
| 5. Seed Round | 16-Apr-2018 | 000 | 00.00 | Completed | Generating Revenue | |
| 4. Later Stage VC (Series A) | 22-Feb-2018 | 000 | Cancelled | Product In Beta Test | ||
| 3. Grant | 15-Jan-2018 | 00.00 | 00.00 | Completed | Product In Beta Test | |
| 2. Grant | 03-Nov-2017 | $595K | $1.1M | Completed | Product In Beta Test | |
| 1. Seed Round | 31-Aug-2017 | $1.1M | $1.1M | Completed | Product In Beta Test |
SentiAR Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.00 |
| Series A-3 | 000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series A-2 | 658,080 | $0.000010 | 6% | $1.67 | $1.67 | 1x | $1.67 | 11.47% |
| Series A-1 | 157,042 | $0.000010 | 6% | $1.91 | $1.91 | 1x | $1.91 | 2.74% |
SentiAR Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a 3D augmented reality platform designed to transform the experience for both patients and clinicians in in
Surgical Devices
Saint Louis, MO
17
As of 2022
00.00
00.00
0000-00-00
00000000000
00.00
00000000
olore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui of
00000 0000000000 0000000000 0000000
Yokneam, Israel
00
As of 0000
000.00
00000000000
000.00
00000000
te irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Exce
00000 0000000000 0000000000 0000000
Santa Clara, CA
00
As of 0000
000.00
000000000 -
000.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialSentiAR Competitors (9)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| RealView (Other Healthcare Technology Systems) | Venture Capital-Backed | Yokneam, Israel | 00 | 000.00 | 00000000000 | 000.00 |
| 000000000 | Venture Capital-Backed | Santa Clara, CA | 00 | 000.00 | 000000000 - | 000.00 |
| 00000000 0000000 | Venture Capital-Backed | Los Angeles, CA | 00 | 000.00 | 000000000 - | 000.00 |
| 000000000 | Venture Capital-Backed | Chicago, IL | 00 | 000.00 | 00000000000 | 000.00 |
| 00000000 | Venture Capital-Backed | Milan, Italy | 00 | 00.000 | 00000000000 | 00.000 |
SentiAR Patents
SentiAR Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210121089-A1 | Electrogram annotation system | Pending | 25-Oct-2019 | 000000000 | |
| US-20210224020-A1 | Augmented reality display sharing | Pending | 13-Feb-2018 | 0000000000 | |
| US-20190250873-A1 | Augmented reality display sharing | Granted | 13-Feb-2018 | 000000000 | |
| US-11003410-B2 | Augmented reality display sharing | Active | 13-Feb-2018 | 000000000 | 00 |
| US-11126395-B2 | Intercom system for multiple users | Active | 13-Feb-2018 | G06F3/165 | 00 |
SentiAR Executive Team (5)
SentiAR Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Berk Tas | SentiAR | Chief Executive Officer, President & Board Member | 000 0000 |
| Charles Bolten | BioGenerator | Board Member | 000 0000 |
| Jennifer Silva MD | SentiAR | Co-Founder, Chief Medical Officer & Board Member | 000 0000 |
| Jonathan Silva | SentiAR | Co-Founder, Chief Technology Officer & Board Member | 000 0000 |
| Shlomo Shpun | Self | Board Member | 000 0000 |
SentiAR Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSentiAR Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Harmonix Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Keiretsu Forum | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Militello Capital | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Service Provider Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Techwald Holding | Corporation | Minority | 000 0000 | 000000 0 |